Changes in the cup-to-disc ratio in patients with diabetic macular edema (DME) treated with fluocinolone acetonide (FAc) implants

被引：0
|
作者：
Parrish, Richard K. [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Ophthal Bascom Palmer Eye Inst, Miami, FL 33136 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
568 intraocular pressure; 487; corticosteroids;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1784
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Prior steroid response as a predictor of real-world IOP safety with 0.2 μg/day fluocinolone acetonide (FAc) in diabetic macular edema (DME) therapy
    Lai, James C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [22] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [23] Sustained Delivery Fluocinolone Acetonide Vitreous Implants Long-Term Benefit in Patients with Chronic Diabetic Macular Edema
    Cunha-Vaz, Jose
    Ashton, Paul
    Iezzi, Raymond
    Campochiaro, Peter
    Dugel, Pravin U.
    Holz, Frank G.
    Weber, Michel
    Danis, Ronald P.
    Kuppermann, Baruch D.
    Bailey, Clare
    Billman, Kathleen
    Kapik, Barry
    Kane, Frances
    Green, Ken
    OPHTHALMOLOGY, 2014, 121 (10) : 1892 - +
  • [24] Fluocinolone acetonide intravitreal implant in patients with diabetic macular edema: 12 month results
    Pearson, P
    Baker, CW
    Eliott, D
    Ip, MS
    Morse, LS
    Callanan, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U489 - U489
  • [25] Retinal thickness fluctuations in patients receiving fluocinolone acetonide implant for diabetic macular edema
    Holden, Sarah E.
    Habib, Maged
    Currie, Craig J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 959 - 965
  • [26] Efficacy and Safety of Fluocinolone acetonide (FAc) implant (ILUVIEN) for treating Diabetic Macular Edema (DME) - A 3-year US Retrospective, multi-center Audit
    Wang, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [27] Early central subfield thickness and long-term visual acuity changes with fluocinolone acetonide (FAc)-associated continuous microdosing in diabetic macular edema
    Luo, Caesar
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [28] The outcome of chronic diabetic macular oedema in patients treated with intravitreal Fluocinolone acetonide (Iluvien)
    El-Ghrably, Ibraheem
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema
    Capone, Luigi
    Airaghi, Pietro
    Aragona, Pasquale
    Castellino, Nicolo
    Cicinelli, Maria Vittoria
    Ciucci, Francesco
    Coppola, Michele
    De Gaetano, Cristiano
    Lattanzio, Rosangela
    Lorusso, Massimo
    Maceroni, Martina
    Malvasi, Maria Elena
    Marco, Luisa
    Marraffa, Michele
    Martini, Gaia
    Mastropasqua, Rodolfo
    Minnella, Angelo Maria
    Nikolopulou, Eleni
    Ortisi, Elina
    Pacella, Elena
    Papa, Vincenzo
    Pennesi, Claudio
    Reibaldi, Michele
    Rizzo, Stanislao
    Toto, Lisa
    Trombetta, Luigi
    Bandello, Francesco
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (06) : 1837 - 1842
  • [30] 36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN).
    Putri, Christine Anggun
    Quhill, Fahd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345